162 related articles for article (PubMed ID: 20197136)
1. The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant.
Chen W; Kuolee R; Yan H
Vaccine; 2010 Apr; 28(18):3080-5. PubMed ID: 20197136
[TBL] [Abstract][Full Text] [Related]
2. The effect of c-di-GMP (3'-5'-cyclic diguanylic acid) on the biofilm formation and adherence of Streptococcus mutans.
Yan W; Qu T; Zhao H; Su L; Yu Q; Gao J; Wu B
Microbiol Res; 2010 Feb; 165(2):87-96. PubMed ID: 19186044
[TBL] [Abstract][Full Text] [Related]
3. 3',5'-Cyclic diguanylic acid: a small nucleotide that makes big impacts.
Yan H; Chen W
Chem Soc Rev; 2010 Aug; 39(8):2914-24. PubMed ID: 20577685
[TBL] [Abstract][Full Text] [Related]
4. c-di-GMP-mediated regulation of virulence and biofilm formation.
Cotter PA; Stibitz S
Curr Opin Microbiol; 2007 Feb; 10(1):17-23. PubMed ID: 17208514
[TBL] [Abstract][Full Text] [Related]
5. 3',5'-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation.
Karaolis DK; Cheng K; Lipsky M; Elnabawi A; Catalano J; Hyodo M; Hayakawa Y; Raufman JP
Biochem Biophys Res Commun; 2005 Apr; 329(1):40-5. PubMed ID: 15721270
[TBL] [Abstract][Full Text] [Related]
6. Cyclic di-GMP signalling controls virulence properties of Salmonella enterica serovar Typhimurium at the mucosal lining.
Lamprokostopoulou A; Monteiro C; Rhen M; Römling U
Environ Microbiol; 2010 Jan; 12(1):40-53. PubMed ID: 19691499
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of bis-carbamate analogs of cyclic bis-(3'-5')-diguanylic acid (c-di-GMP) and the acyclic dimer PGPG.
Kline T; Jackson SR; Deng W; Verlinde CL; Miller SI
Nucleosides Nucleotides Nucleic Acids; 2008 Dec; 27(12):1282-300. PubMed ID: 19003573
[TBL] [Abstract][Full Text] [Related]
8. Cyclic di-GMP as a second messenger.
Römling U; Amikam D
Curr Opin Microbiol; 2006 Apr; 9(2):218-28. PubMed ID: 16530465
[TBL] [Abstract][Full Text] [Related]
9. Bacterial c-di-GMP is an immunostimulatory molecule.
Karaolis DK; Means TK; Yang D; Takahashi M; Yoshimura T; Muraille E; Philpott D; Schroeder JT; Hyodo M; Hayakawa Y; Talbot BG; Brouillette E; Malouin F
J Immunol; 2007 Feb; 178(4):2171-81. PubMed ID: 17277122
[TBL] [Abstract][Full Text] [Related]
10. Cyclic di-GMP activation of polynucleotide phosphorylase signal-dependent RNA processing.
Tuckerman JR; Gonzalez G; Gilles-Gonzalez MA
J Mol Biol; 2011 Apr; 407(5):633-9. PubMed ID: 21320509
[TBL] [Abstract][Full Text] [Related]
11. c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation.
Karaolis DK; Rashid MH; Chythanya R; Luo W; Hyodo M; Hayakawa Y
Antimicrob Agents Chemother; 2005 Mar; 49(3):1029-38. PubMed ID: 15728899
[TBL] [Abstract][Full Text] [Related]
12. Phosphate-dependent modulation of c-di-GMP levels regulates Pseudomonas fluorescens Pf0-1 biofilm formation by controlling secretion of the adhesin LapA.
Monds RD; Newell PD; Gross RH; O'Toole GA
Mol Microbiol; 2007 Feb; 63(3):656-79. PubMed ID: 17302799
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of diguanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for high-throughput screening of biofilm inhibitors.
Antoniani D; Bocci P; Maciag A; Raffaelli N; Landini P
Appl Microbiol Biotechnol; 2010 Jan; 85(4):1095-104. PubMed ID: 19707751
[TBL] [Abstract][Full Text] [Related]
14. Thiazole orange-induced c-di-GMP quadruplex formation facilitates a simple fluorescent detection of this ubiquitous biofilm regulating molecule.
Nakayama S; Kelsey I; Wang J; Roelofs K; Stefane B; Luo Y; Lee VT; Sintim HO
J Am Chem Soc; 2011 Apr; 133(13):4856-64. PubMed ID: 21384923
[TBL] [Abstract][Full Text] [Related]
15. Multiple activities of c-di-GMP in Pseudomonas aeruginosa.
Lory S; Merighi M; Hyodo M
Nucleic Acids Symp Ser (Oxf); 2009; (53):51-2. PubMed ID: 19749255
[TBL] [Abstract][Full Text] [Related]
16. The cAMP receptor-like protein CLP is a novel c-di-GMP receptor linking cell-cell signaling to virulence gene expression in Xanthomonas campestris.
Chin KH; Lee YC; Tu ZL; Chen CH; Tseng YH; Yang JM; Ryan RP; McCarthy Y; Dow JM; Wang AH; Chou SH
J Mol Biol; 2010 Feb; 396(3):646-62. PubMed ID: 20004667
[TBL] [Abstract][Full Text] [Related]
17. C-di-GMP: the dawning of a novel bacterial signalling system.
Römling U; Gomelsky M; Galperin MY
Mol Microbiol; 2005 Aug; 57(3):629-39. PubMed ID: 16045609
[TBL] [Abstract][Full Text] [Related]
18. The role of c-di-GMP signaling in an Aeromonas veronii biovar sobria strain.
Rahman M; Simm R; Kader A; Basseres E; Römling U; Möllby R
FEMS Microbiol Lett; 2007 Aug; 273(2):172-9. PubMed ID: 17573931
[TBL] [Abstract][Full Text] [Related]
19. A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy.
Miyabe H; Hyodo M; Nakamura T; Sato Y; Hayakawa Y; Harashima H
J Control Release; 2014 Jun; 184():20-7. PubMed ID: 24727060
[TBL] [Abstract][Full Text] [Related]
20. 3',5'-cyclic diguanylic acid reduces the virulence of biofilm-forming Staphylococcus aureus strains in a mouse model of mastitis infection.
Brouillette E; Hyodo M; Hayakawa Y; Karaolis DK; Malouin F
Antimicrob Agents Chemother; 2005 Aug; 49(8):3109-13. PubMed ID: 16048911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
